Werewolf Therapeutics Inc (NASDAQ: HOWL) on Friday, plunged -5.76% from the previous trading day, before settling in for the closing price of $1.39. Within the past 52 weeks, HOWL’s price has moved between $0.60 and $4.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -20.76% annually for the last half of the decade. The company achieved an average annual earnings per share of 5.52%. With a float of $33.92 million, this company’s outstanding shares have now reached $45.34 million.
Werewolf Therapeutics Inc (HOWL) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Werewolf Therapeutics Inc is 25.83%, while institutional ownership is 34.32%. The most recent insider transaction that took place on May 12 ’25, was worth 275,985. In this transaction Director of this company bought 320,913 shares at a rate of $0.86, taking the stock ownership to the 6,021,969 shares. Before that another transaction happened on May 14 ’25, when Company’s Director bought 162,539 for $0.98, making the entire transaction worth $159,288. This insider now owns 6,237,482 shares in total.
Werewolf Therapeutics Inc (HOWL) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 5.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.20% during the next five years compared to -20.76% drop over the previous five years of trading.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Trading Performance Indicators
Werewolf Therapeutics Inc (HOWL) is currently performing well based on its current performance indicators. A quick ratio of 5.30 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.64, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.27 in one year’s time.
Technical Analysis of Werewolf Therapeutics Inc (HOWL)
Let’s dig in a bit further. During the last 5-days, its volume was 0.13 million. That was inferior than the volume of 0.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 68.25%.
During the past 100 days, Werewolf Therapeutics Inc’s (HOWL) raw stochastic average was set at 77.78%, which indicates a significant increase from 59.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0821 in the past 14 days, which was lower than the 0.0975 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2449, while its 200-day Moving Average is $1.2922. However, in the short run, Werewolf Therapeutics Inc’s stock first resistance to watch stands at $1.3700. Second resistance stands at $1.4300. The third major resistance level sits at $1.4600. If the price goes on to break the first support level at $1.2800, it is likely to go to the next support level at $1.2500. The third support level lies at $1.1900 if the price breaches the second support level.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Key Stats
Market capitalization of the company is 59.90 million based on 45,729K outstanding shares. Right now, sales total 1,890 K and income totals -70,520 K. The company made 0 K in profit during its latest quarter, and -17,980 K in sales during its previous quarter.
